Grantham, Mayo, Van Otterloo & Co (GMO)’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-279,400
Closed -$15.7M 743
2019
Q2
$15.7M Buy
+279,400
New +$14.5M 0.11% 140

Other funds holding DVA

Grantham, Mayo, Van Otterloo & Co (GMO)'s DVA Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of DaVita (DVA) in Q3 2022, closing a stake of 9,727 shares — an estimated $778K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DVA in Q2 2019 and held it in 8 quarters. The position peaked at $29.2M in Q2 2019. 443 funds tracked by Wall St. Rank hold DVA as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining DaVita position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,727 DaVita shares in Q3 2022, an estimated $778K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DaVita in Q2 2019 and held it in 8 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s DaVita position peaked at $29.2M in Q2 2019.
  • 443 funds tracked by Wall St. Rank held DaVita as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.